# Inbrain Neuroelectronics S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inbrain-neuroelectronics-s-l

- Industry: Medical Devices & Equipment
- Headquarters: Barcelona, Spain
- Website: www.inbrain-neuroelectronics.com
- Total disclosed funding: $68M
- Latest round: Series B (Oct 29, 2024)
- Investors on record: 14

## About

Based in Barcelona, Spain, and founded in 2019 by CEO & founder Carolina Aguilar and CSO & founder Jose A Garrido, Inbrain Neuroelectronics S.L. a.k.a. Inbrain Neuroelectronics, operate as a developer of invasive procedures and neural interface solutions in neuroelectronic therapies for treating patients with epilepsy, Parkinson's disease, and other neuronal illnesses. In October 2024, Inbrain Neuroelectronics S.L. raised USD 50 million in series B funding led by new investor Imec.xpand, with participation from returning investors Asabys Partners, Aliath Bioventures, and Vsquared Ventures. Other new investors Avancsa, EIC Fund, Instituto de Crédito Oficial, and Centre for the Development of Industrial Technology also participated in the round.

Inbrain Neuroelectronics provides and develops graphene for neural Interfaces, a comprehensive AI (artificial intelligence), machine learning, and data-driven neural platform that offers insights to support practitioners, empowers patients, and enables individualized care. The company also provides central system neuroelectronics (INBRAIN), peripheral system bioelectronics (INNERVIA), and an intelligent data platform, which is a data hub to drive personalized neural digital therapeutics using real-time data processing with predictions and risk stratification tools.

## Funding rounds

- Series B, Oct 29, 2024, $50M — Instituto de Crédito Oficial, Merck KGaA, Imec.xpand, Avancsa, Asabys Partners, European Innovation Council, Vsquared Ventures, Center for Technological & Industrial Development, Aliath Bioventures
- Series A, Mar 26, 2021, $17M — TruVenturo, ICF Capital, Asabys Partners, Alta Life Sciences, Vsquared Ventures, Center for Technological & Industrial Development
- Seed, Jun 11, 2020, $1.2M — Finaves, ICF Capital, Asabys Partners, Alta Life Sciences, Catalan Institute of Nanoscience and Nanotechnology

## Investors

- Finaves (https://capitalatlas.ai/funds/finaves) — Seed
- ICF Capital (https://capitalatlas.ai/funds/icf-capital) — Seed, Series A
- Asabys Partners (https://capitalatlas.ai/funds/asabys-partners) — Seed, Series A, Series B
- Alta Life Sciences — Seed, Series A
- Catalan Institute of Nanoscience and Nanotechnology — Seed
- TruVenturo (https://capitalatlas.ai/funds/truventuro) — Series A
- Vsquared Ventures (https://capitalatlas.ai/funds/vsquared-ventures) — Series A, Series B
- Center for Technological & Industrial Development (https://capitalatlas.ai/funds/center-for-technological-industrial-development) — Series A, Series B
- Instituto de Crédito Oficial — Series B
- Merck KGaA — Series B
- Imec.xpand (https://capitalatlas.ai/funds/imec-xpand) — Series B
- Avancsa — Series B
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series B
- Aliath Bioventures — Series B